Actuate Therapeutics, Inc. · NASDAQ:ACTU
Schmitt Daniel M bought 140,844 Actuate Therapeutics, Inc. shares (Form 4)
Traded Oct 28, 2026 · Filed Oct 29, 2026
On Oct 28, 2026, Schmitt Daniel M (Director, President, CEO and Director) bought 140,844 Actuate Therapeutics, Inc. shares at US$0.36 for US$50,000, leaving 442,560 shares. Filed Oct 29, 2026 (Form 4).
- Bought
- 140,844 shares
- Price
- US$0.36
- Value
- US$50,000
- Holding after
- 442,560 shares
- Trading plan
- No
- Role
- Director, President, CEO and Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 28, 2026 | Common Stock | Buy | 140,844 | US$0.36 | 442,560 | Direct |
Source
Download original · View original at SEC
Related
- Actuate Therapeutics, Inc.
- Schmitt Daniel M
- Actuate Therapeutics, Inc. shareholders
- Form 4 · Schmitt Daniel M · Aug 14, 2026
- Schedule 13G · Hexstone Capital LLC · Oct 30, 2026
- Schedule 13G/A · Voss Capital, LP · Apr 22, 2026
- Schedule 13G · Voss Capital, LP · Dec 17, 2025
- Schedule 13D/A · Fletcher Aaron G.L. · Jun 30, 2025
- Schedule 13D/A · BIOS Advisors GP, LLC · May 27, 2025